Robert Sutherland Smith

GlaxoSmithKline: Turning a Corner in Q1

GlaxoSmithKline: Turning a Corner in Q1

6 mins. to read

The evidence of the optimistic recovery plan at GSK is borne out in the first-quarter results and management have gone as far as they can go in giving confidence to an 80p dividend payout this year and next. The shares represent a well paid rational speculation on longer term earnings recovery, in my opinion.  …

Market Tactics Ahead of the Brexit Vote

Market Tactics Ahead of the Brexit Vote

7 mins. to read

The market now resembles one of those challenging Harold Pinter plays where the dialogue of the characters is mysteriously compelling but outwardly meaningless, because Pinter avoids putting it into a plotted or themed context. ‘What’s he on about?’ whispers one member of the audience, nudging the one next to him. ‘No idea!’ responds the ‘nudgee’!…

Brexit: Caveat Emptor!

Brexit: Caveat Emptor!

6 mins. to read

Market Latin: ‘caveat emptor’ says the Governor; ‘Et tu Brute’ rejoin shocked British Brexiteers; ‘Quo Vadis?’ shout investors. Will a Brexit vote be bad for the equity market, and if so, what sectors is a Brexit vote likely to hurt?     The Governor of the Bank of England’s foray into Brexit prophecy has provoked outrage…

Plenty More Puff in Imperial Brands

Plenty More Puff in Imperial Brands

7 mins. to read

At 3,783p a share, Imperial Brands offers an estimated strongly increasing dividend payout, giving an equally attractive estimated dividend yield for this year and next.    The business Imperial Tobacco is no more: it is now known by the less pejorative and much blander name of Imperial Brands (IMB); its share price mnemonic has changed…

President Trump

President Trump

6 mins. to read

In the words of Bob Dylan, ‘the times, they are a changing’ Sitting through Donald Trump’s speech after the results of the Indiana Primary, which saw the withdrawal of Ted Cruz (who, like someone else, also has eyes like Caligula) and the triumph of Donald Trump himself, I pondered how the world had changed and…

Recovery in Play at Barclays?

Recovery in Play at Barclays?

4 mins. to read

Since this is the month for quoting Shakespeare, I point out that although a rose may smell just as sweet by any other name, a share smells twice as sweet to a buyer, if the share price increases significantly thereafter. Consequently the aroma of Barclays Bank at 175p, last seen, seems endearingly more fragrant than…

Better Times Ahead for BP?

Better Times Ahead for BP?

7 mins. to read

The first quarter results from BP are essentially good news, although complex in analysis. Here is my “hot towel around the head” best assessment of them. They offer rational grounds for expectation of strong recovery next year and a super normal dividend yield that the company wants to maintain. These shares continue to look very attractive…

Still Flying High at IAG

Still Flying High at IAG

5 mins. to read

I have taken another look at International Consolidated Airlines Group, which has come down 15% from 619p last December to 529p last seen. The fundamentals look highly encouraging for seekers of dividends and I believe the shares look extremely good value. They are denominated in Euros, and if the Euro was to weaken on a Brexit…

GKN Driving Ahead

GKN Driving Ahead

6 mins. to read

GKN (GKN) bounced cheerfully at the Trading Statement. But on first inspection it is difficult to discern what it was that got the market so positively enthusiastic: as the great Trump of Oz might say, “What the hell is going on here?” However, the reasonable price to earnings ratio, the prospective estimated dividend yield of…